drug · vaccine component
respiratory syncytial virus vaccine
Phase 2updated 3mo agoby $MRNA Moderna, Inc.🔗 ChEMBL
Phase 2community read0 votes
Vaccine component drug with a maximum clinical stage of Approval, with an approval for respiratory syncytial virus infection.
targets
Fusion glycoprotein F0
all catalysts(0)
nothing on the calendar yet
Trials studying respiratory syncytial virus vaccine
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 39m ago
Found something off?
comments(0)
5-min edit window · permanent after that